• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有新型突变的2岁和3岁意大利肌萎缩侧索硬化症患者:血清和血浆中关键代谢物的鉴定

2-Year-Old and 3-Year-Old Italian ALS Patients with Novel Mutations: Identification of Key Metabolites in Their Serum and Plasma.

作者信息

Gautam Mukesh, Carratore Renata Del, Helmold Benjamin, Tessa Alessandra, Gozutok Oge, Chandel Navdeep, Idrisoglu Halil, Bongioanni Paolo, Battini Roberta, Ozdinler P Hande

机构信息

Department of Neurology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Ave, Chicago, IL 60611, USA.

Clinical Physiology Institute of National Council of Research, Via Moruzzi 1, 56100 Pisa, Italy.

出版信息

Metabolites. 2022 Feb 12;12(2):174. doi: 10.3390/metabo12020174.

DOI:10.3390/metabo12020174
PMID:35208248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8878019/
Abstract

Pathogenic variants in have been detected mostly in juvenile cases of amyotrophic lateral sclerosis (ALS), affecting mainly children and teenagers. Patients with mutations demonstrate early onset cortical involvement in ALS. Currently, there are no effective treatment options. There is an immense need to reveal the underlying causes of the disease and to identify potential biomarkers. To shed light onto the metabolomic events that are perturbed with respect to mutations, we investigated the metabolites present in the serum and plasma of a three-year-old female patient (AO) harboring pathogenic variants in , together with her relatives, healthy male and female controls, as well as another two-year-old patient DH, who had mutations at different locations and domains of . Serum and plasma samples were analyzed with a quantitative metabolomic approach to reveal the identity of metabolites present in serum and plasma. This study not only shed light onto the perturbed cellular pathways, but also began to reveal the presence of a distinct set of key metabolites that are selectively present or absent with respect to mutations, laying the foundation for utilizing metabolites as potential biomarkers for a subset of ALS.

摘要

已在肌萎缩侧索硬化症(ALS)的青少年病例中大多检测到[具体基因名称]的致病变体,主要影响儿童和青少年。携带[具体基因名称]突变的患者在ALS中表现出早期皮质受累。目前,尚无有效的治疗选择。迫切需要揭示该疾病的潜在病因并确定潜在的生物标志物。为了阐明与[具体基因名称]突变相关的代谢组学事件,我们研究了一名携带[具体基因名称]致病变体的三岁女性患者(AO)及其亲属、健康男性和女性对照以及另一名两岁患者DH(其[具体基因名称]在不同位置和结构域发生突变)的血清和血浆中的代谢物。采用定量代谢组学方法分析血清和血浆样本,以揭示血清和血浆中存在的代谢物的身份。这项研究不仅阐明了受干扰的细胞途径,还开始揭示存在一组独特的关键代谢物,它们相对于[具体基因名称]突变有选择性地存在或不存在,为将代谢物用作一部分ALS的潜在生物标志物奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/f3e02fc2cd07/metabolites-12-00174-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/c2a665664a92/metabolites-12-00174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/34d85b953071/metabolites-12-00174-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/f52628c78c22/metabolites-12-00174-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/3f197ebcf732/metabolites-12-00174-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/0b1ade5b977d/metabolites-12-00174-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/f3e02fc2cd07/metabolites-12-00174-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/c2a665664a92/metabolites-12-00174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/34d85b953071/metabolites-12-00174-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/f52628c78c22/metabolites-12-00174-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/3f197ebcf732/metabolites-12-00174-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/0b1ade5b977d/metabolites-12-00174-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/8878019/f3e02fc2cd07/metabolites-12-00174-g006.jpg

相似文献

1
2-Year-Old and 3-Year-Old Italian ALS Patients with Novel Mutations: Identification of Key Metabolites in Their Serum and Plasma.患有新型突变的2岁和3岁意大利肌萎缩侧索硬化症患者:血清和血浆中关键代谢物的鉴定
Metabolites. 2022 Feb 12;12(2):174. doi: 10.3390/metabo12020174.
2
Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.七种携带新型 ALS2 突变的运动神经元病家系的基因型-表型相关性研究。
Am J Med Genet A. 2021 Feb;185(2):344-354. doi: 10.1002/ajmg.a.61951. Epub 2020 Nov 5.
3
Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.肌萎缩侧索硬化症2缺陷通过改变AMPA受体运输导致肌萎缩侧索硬化症中的神经元变性。
J Neurosci. 2006 Nov 8;26(45):11798-806. doi: 10.1523/JNEUROSCI.2084-06.2006.
4
Single-nucleotide polymorphisms in uncoding regions of ALS2 gene of Japanese patients with autosomal-recessive amyotrophic lateral sclerosis.常染色体隐性遗传性肌萎缩侧索硬化症日本患者ALS2基因非编码区的单核苷酸多态性
Neurol Res. 2003 Jul;25(5):505-9. doi: 10.1179/016164103101201733.
5
A novel mutation in the ALS2 gene in an iranian kurdish family with juvenile amyotrophic lateral sclerosis.一个伊朗库尔德家族的少年型肌萎缩侧索硬化症中 ALS2 基因的新突变。
Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):148-151. doi: 10.1080/21678421.2022.2100263. Epub 2022 Jul 19.
6
Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function.与青少年运动神经元疾病相关的致病性 ALS2 变异体中寡聚状态的改变导致 ALS2 介导的内体功能丧失。
J Biol Chem. 2018 Nov 2;293(44):17135-17153. doi: 10.1074/jbc.RA118.003849. Epub 2018 Sep 17.
7
The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function.首个与青少年原发性侧索硬化症相关的肌萎缩侧索硬化症2型错义突变揭示了alsin生物学功能的新方面。
Brain. 2006 Jul;129(Pt 7):1710-9. doi: 10.1093/brain/awl104. Epub 2006 May 2.
8
Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C>T.因 novel ALS2 突变 c.2761C>T 导致婴儿起病的进行性遗传性痉挛性截瘫伴球部受累。
Gene. 2014 Feb 15;536(1):217-20. doi: 10.1016/j.gene.2013.11.043. Epub 2013 Dec 4.
9
Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis.散发性和家族性肌萎缩侧索硬化症中ALS2基因的突变筛查
Arch Neurol. 2003 Dec;60(12):1768-71. doi: 10.1001/archneur.60.12.1768.
10
and Variants in a Family With Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis.遗传性痉挛性截瘫和肌萎缩侧索硬化症家族中的基因变异
Front Neurol. 2018 Dec 7;9:1078. doi: 10.3389/fneur.2018.01078. eCollection 2018.

引用本文的文献

1
Multiomics Approach Reveal Novel Insights in FUS Driven Juvenile Amyotrophic Lateral Sclerosis: A Family Quartet Analysis.多组学方法揭示FUS驱动的青少年肌萎缩侧索硬化症的新见解:一个家族四重奏分析
Ann Neurosci. 2025 Apr;32(2):78-89. doi: 10.1177/09727531231194399. Epub 2023 Oct 2.
2
Spastin and alsin protein interactome analyses begin to reveal key canonical pathways and suggest novel druggable targets.痉挛素和alsin蛋白相互作用组分析开始揭示关键的经典信号通路,并提示新的可成药靶点。
Neural Regen Res. 2025 Mar 1;20(3):725-739. doi: 10.4103/NRR.NRR-D-23-02068. Epub 2024 May 13.
3
Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies.

本文引用的文献

1
A six-metabolite panel as potential blood-based biomarkers for Parkinson's disease.作为帕金森病潜在血液生物标志物的六种代谢物组合
NPJ Parkinsons Dis. 2021 Oct 14;7(1):94. doi: 10.1038/s41531-021-00239-x.
2
Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites.痴呆症患者全血代谢组学揭示了与疾病相关的代谢物类别。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2022857118.
3
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.MetaboAnalyst 5.0:缩小原始光谱与功能见解之间的差距。
基于计算机模拟策略的婴儿进行性遗传性痉挛性截瘫的个体化治疗。
Molecules. 2022 Oct 19;27(20):7063. doi: 10.3390/molecules27207063.
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396. doi: 10.1093/nar/gkab382.
4
Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.七种携带新型 ALS2 突变的运动神经元病家系的基因型-表型相关性研究。
Am J Med Genet A. 2021 Feb;185(2):344-354. doi: 10.1002/ajmg.a.61951. Epub 2020 Nov 5.
5
Circulating Metabolites as Potential Biomarkers for Neurological Disorders-Metabolites in Neurological Disorders.循环代谢物作为神经系统疾病的潜在生物标志物——神经系统疾病中的代谢物
Metabolites. 2020 Sep 29;10(10):389. doi: 10.3390/metabo10100389.
6
Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology.令人兴奋的复杂性:运动回路元件在肌萎缩侧索硬化症病理生理学中的作用
Front Neurosci. 2020 Jun 17;14:573. doi: 10.3389/fnins.2020.00573. eCollection 2020.
7
Clean Production of Levulinic Acid from Fructose and Glucose in Salt Water by Heterogeneous Catalytic Dehydration.通过非均相催化脱水由果糖和葡萄糖在盐水中清洁生产乙酰丙酸
ACS Omega. 2020 Jun 11;5(24):14275-14282. doi: 10.1021/acsomega.9b04406. eCollection 2020 Jun 23.
8
Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?神经退行性疾病——代谢缺陷是根本原因吗?
Front Neurosci. 2020 Mar 31;14:213. doi: 10.3389/fnins.2020.00213. eCollection 2020.
9
Catalytic Production of Levulinic Acid (LA) from Actual Biomass.从实际生物质中催化生产乙酰丙酸(LA)。
Molecules. 2019 Jul 30;24(15):2760. doi: 10.3390/molecules24152760.
10
Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function.与青少年运动神经元疾病相关的致病性 ALS2 变异体中寡聚状态的改变导致 ALS2 介导的内体功能丧失。
J Biol Chem. 2018 Nov 2;293(44):17135-17153. doi: 10.1074/jbc.RA118.003849. Epub 2018 Sep 17.